These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 30450045

  • 1. Predicting Responses to Psychedelics: A Prospective Study.
    Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, Nutt D, Daws RE, Hampshire ADG, Lorenz R, Carhart-Harris RL.
    Front Pharmacol; 2018; 9():897. PubMed ID: 30450045
    [Abstract] [Full Text] [Related]

  • 2. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
    Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R.
    J Psychopharmacol; 2019 Sep; 33(9):1076-1087. PubMed ID: 31294673
    [Abstract] [Full Text] [Related]

  • 3. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.
    Kuc J, Kettner H, Rosas F, Erritzoe D, Haijen E, Kaelen M, Nutt D, Carhart-Harris RL.
    Psychopharmacology (Berl); 2022 May; 239(5):1425-1440. PubMed ID: 34734314
    [Abstract] [Full Text] [Related]

  • 4. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
    Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D.
    J Psychopharmacol; 2022 Aug; 36(8):932-942. PubMed ID: 35924888
    [Abstract] [Full Text] [Related]

  • 5. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
    Roseman L, Nutt DJ, Carhart-Harris RL.
    Front Pharmacol; 2017 Aug; 8():974. PubMed ID: 29387009
    [Abstract] [Full Text] [Related]

  • 6. Validation of the imperial psychedelic predictor scale.
    Angyus M, Osborn S, Haijen E, Erritzoe D, Peill J, Lyons T, Kettner H, Carhart-Harris R.
    Psychol Med; 2024 Sep 27; 54(12):1-9. PubMed ID: 39327922
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
    Nour MM, Evans L, Nutt D, Carhart-Harris RL.
    Front Hum Neurosci; 2016 Sep 27; 10():269. PubMed ID: 27378878
    [Abstract] [Full Text] [Related]

  • 10. Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.
    Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR.
    Front Psychol; 2017 Sep 27; 8():1238. PubMed ID: 28790944
    [Abstract] [Full Text] [Related]

  • 11. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
    Sweat NW, Bates LW, Hendricks PS.
    J Psychoactive Drugs; 2016 Sep 27; 48(5):344-350. PubMed ID: 27719438
    [Abstract] [Full Text] [Related]

  • 12. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW, Hendricks PS, Barrett FS, Griffiths RR.
    Pharmacol Ther; 2019 May 27; 197():83-102. PubMed ID: 30521880
    [Abstract] [Full Text] [Related]

  • 13. Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.
    Barbut Siva J, Barba T, Kettner H, Kuc J, Nutt DJ, Carhart-Harris R, Erritzoe D.
    J Psychopharmacol; 2024 Feb 27; 38(2):145-155. PubMed ID: 38281075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.
    Davis AK, Barrett FS, Griffiths RR.
    J Contextual Behav Sci; 2020 Jan 27; 15():39-45. PubMed ID: 32864325
    [Abstract] [Full Text] [Related]

  • 16. Psychedelics and hypnosis: Commonalities and therapeutic implications.
    Lemercier CE, Terhune DB.
    J Psychopharmacol; 2018 Jul 27; 32(7):732-740. PubMed ID: 29938563
    [Abstract] [Full Text] [Related]

  • 17. The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity.
    Hartogsohn I.
    Front Neurosci; 2018 Jul 27; 12():129. PubMed ID: 29559884
    [Abstract] [Full Text] [Related]

  • 18. Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing.
    Qiu TT, Minda JP.
    J Psychoactive Drugs; 2023 Jul 27; 55(2):123-133. PubMed ID: 35438609
    [Abstract] [Full Text] [Related]

  • 19. The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.
    Winkelman MJ.
    Front Pharmacol; 2021 Jul 27; 12():619890. PubMed ID: 33732156
    [Abstract] [Full Text] [Related]

  • 20. Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use.
    Hübner S, Haijen E, Kaelen M, Carhart-Harris RL, Kettner H.
    J Med Internet Res; 2021 Jul 28; 23(7):e25973. PubMed ID: 34319246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.